<DOC>
	<DOC>NCT00596973</DOC>
	<brief_summary>The aim of this study is to assess the short term success and feasibility of ileal transposition with sleeve gastrectomy in non-morbidly obese patients with poorly controlled Type 2 Diabetes Mellitus</brief_summary>
	<brief_title>Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>1. Diagnosed Type 2 Diabetes for 3 to 5 years. 2. Poorly controlled blood sugar despite standard of care* as demonstrated by HbA1c 811 for at least 6 months and 3 office visits. Standard of care is based on the ADA (American Diabetes Association) guidelines which include nutrition, exercise, education, behavior modification and pharmacological treatment. A coinvestigator endocrinologist will ensure that the above standard of care has been met. 3. BMI between 25.0 and 34.4. 4. Stable weight as determined by no more than a 3% change in body weight in the last 3 months. 5. Age between 35 and 65 (both men and women will be included). 6. Able to provide Informed Consent. 7. Able to comply with followup procedures. 1. Previous history of major abdominal surgery which may lead to a hostile abdomen. 2. Pregnancy 3. Patients who have an incurable malignant or debilitating disease 4. Serious uncorrectable impairment of coagulation (INR&gt;1.4, PTT &gt; + 3 secs), lungs, kidney or heart 5. Diagnosed severe eating disorder 6. Use of medication for weight loss in the last 6 months 7. Untreated endocrine disorder 8. Active peptic ulcer 9. Untreated H. pylori 10. Cognitive Impairment 11. Diabetic autonomic neuropathy 12. Symptomatic gastroparesis</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>